Follitropin alfa versus follitropin alfa/lutropin alfa (rFSH/rLH) in progestin-primed ovarian stimulation: a prospective two-center observational cohort study
Authors:
Open Access
- 3 November 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Reproductive Health
- Vol. 8, 1948337
Abstract
Background: The contribution of recombinant LH during progestin-primed ovarian stimulation (PPOS) remains uncertain. We compared recombinant FSH alone (GON) with recombinant FSH plus recombinant LH (PER) in a prospective two-center observational cohort. Methods: The full enrolled cohort included 213 women (121 GON; 92 PER), including 11 with day-3 transfer. MII oocyte count was the primary outcome. The primary negative binomial model adjusted for female age, AMH, baseline AFC, previous failed cycles and center. Propensity scores used the same covariates; matching was 1:1, exact within center, using Mahalanobis distance within a logit propensity-score caliper. The per-protocol (PP) population comprised the 202 women whose embryos were cultured to day 5; in the full-cohort (ITT) analysis, the 11 women with day-3 transfer contributed zero day-5 blastocysts. Results: The primary adjusted MII incidence rate ratio (IRR) for PER versus GON was 1.01 (95% CI 0.91–1.11; p = 0.910); the PP IRR was 1.00 (95% CI 0.91–1.11; p = 0.939). The number of MII oocytes was similar in both groups (median 11 in both), and this finding did not change after adjustment for baseline characteristics or after propensity-score matching. PER was associated with more day-5 blastocysts (median 4 vs. 3) and more top-quality blastocysts (median 2 vs. 1), and these differences persisted after adjustment and matching. Positive β-hCG rates after the first frozen embryo transfer were similar (47.6% vs. 43.2%). OHSS was rare (1 PER and 2 GON cases, all mild), and no cycle was canceled. Conclusions: No statistically significant difference in MII count was detected, and equivalence was not established. The higher day-5 blastocyst counts associated with PER may reflect an effect of LH on embryo developmental competence rather than on oocyte yield; this exploratory finding does not establish a causal or clinical benefit and requires confirmation in randomized trials. https://clinicaltrials.gov/study/NCT07348757 , NCT07348757.Keywords
This publication has 23 references indexed in Scilit:
- The Management of Ovarian Hyperstimulation Syndrome Green‐Top Guideline No. 5BJOG: An International Journal of Obstetrics & Gynaecology, 2026
- ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025Human Reproduction, 2026
- Impact of gonadotropin selection on risk of ovarian hyperstimulation syndrome in predicted high responders: a Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer–High Responder trial analysisF&S Reports, 2025
- Recombinant LH supplementation and cumulative live birth rate in overweight/obese women: a retrospective cohort studyReproductive BioMedicine Online, 2025
- Comparison of highly purified human menopausal gonadotropin and recombinant follicle stimulating hormone use in patients undergoing in vitro fertilization with progestin-primed ovarian stimulation protocol: a single center retrospective analysisArchives of Gynecology and Obstetrics, 2024
- Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysisArchives of Gynecology and Obstetrics, 2021
- Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cyclesCochrane Database of Systematic Reviews, 2017
- ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteriaHuman Reproduction, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity ScoreThe American Statistician, 1985